Events

Meet both new and familiar faces from EU´s largest life science cluster and get your 2024 networking started. Having closed another packed and outstanding year in Medicon Valley with a lot of networking, events and great projects’ start, we look forward to yet another eventful 2024. You are hereby invited to join us in welcoming […]

All projects are different, but a number of parameters are consistent in addition to the guidelines/requirements from ICH, FDA, EMA. Selected characteristics of Small Molecule development projects will be discussed. Highlighting topics concerning: Management of risk and investment Optimization and adaptation of MedChem procedures towards manufacturing Sustainability Introduction of green(-er) chemistry Cost of waste management […]

Join us to gain a greater understanding of the cancer patient journey as our speakers discuss early phase trial design along with optimal data collection and endpoint analysis. You’ll also hear about applying the right digital solutions to balance the needs of the patient, optimizing recruitment and retention and expediting key decision-making. This symposium unites […]

The introduction of IVDR and MDR, in European Union, brought considerably increased regulatory expectations especially in the area of clinical evidence for the industry. Those changes found the industry intrinsically unprepared and lagging the initiative driven approach needed to close the regulatory gaps generated. The state of Clinical Evaluation, PMCF activities and ultimately clinical evidence […]

ATMPs (cell and gene therapies) have the potential to cure currently uncurable diseases by replacing dead or injured cells or broken genes. Remarkable data is presented worldwide from first clinical trials where patients have been cured. The development of these advanced therapies needs novel ways for collaboration between academia, health care and industry for accelerating […]

While much research has focused on the gut microbiome, there is growing interest and recognition that microbiomes in other parts of the body also play crucial roles in human health. At the MVA Microbiome Network meeting we will look into the future of health innovations mediated by the gut, skin, vaginal, and oral microbiomes. The […]

Building upon the insights shared during our Science for Breakfast event on November 14, Saromics Biostructures and SmiLe Incubator will delve deeper into the significance of research infrastructures like MAX IV, DESY, ESS, and European XFEL. They will be detailing their current applications and sharing their industrial experiences during this Science for Lunch session. The […]

Unleashing the Medicon Valley potential Join us at the MVA Annual Summit 2023 for a day focused on unlocking the vast potential of Medicon Valley. This event will bring together industry leaders, researchers, and experts to explore the latest advancements and opportunities in the vibrant Medicon Valley region. Don’t miss out on this opportunity to […]

Medicon Valley Alliance and AbbVie are pleased to invite you to an Abbvie Partnering Day on the 26th of October in Copenhagen. At AbbVie, we partner to achieve two important outcomes: deliver innovative medicines and make a remarkable impact on people’s lives. AbbVie’s Partnering Days provide an opportunity to access senior level Corporate Business Strategy […]

Bridging oral and systemic health For the second year in a row, Medicon Valley Alliance is happy to invite you all to “Dent2Health 2023”, a conference with focus on bridging oral and systemic health. Oral biomarkers, oral screening, and health promotion are some of the topics that will be highlighted during this day. Participants will […]

We invite you to join us for a breakfast meeting centered around the crucial topic of Sponsor oversight for clinical trials, that are partly or fully outsourced to a Contract Research Organizations (CROs). This meeting aims to explore and elucidate the best practices and strategies for ensuring effective oversight in such Sponsor-CRO collaborations. As the […]

Medicon Valley Alliance and Genscript ProBio are pleased to invite you to a Good Morning Meeting on the 5th of October in Copenhagen focusing on accelerated ADC development via integrated antibody discovery platform. Key learning objectives: Brief overview of history and current trending of antibody-drug conjugates Tools and strategies for ADC naked antibody discovery & […]

Medicon Valley Alliance and IQVIA are pleased to invite you to a Good Morning Meeting on the 4th of October in Copenhagen focusing on how to create value for biotech companies through reducing risk, time to market and optimizing peak sales. Early stage biotech companies need to fill the evidence gaps at their stage of […]

Medicon Valley Alliance in Collaboration with BII invites you to join this network meeting on Endometriosis. Endometriosis is a common yet poorly understood condition. Around 10 % of all women in the reproductive age suffer from endometriosis -and yet it takes on average 7,5 years from the onset of symptoms to diagnosis and treatment. Endometriosis […]

A joint meeting of the CINDIS project and the MVA Oncology Network Medicon Valley Alliance (MVA) and the Consortium for Intelligent Diagnostics of Skin Cancer (CINDIS) have the pleasure of inviting you to a joint CINDIS Symposium and MVA Oncology Network meeting about non-invasive diagnosis of skin cancers. It is difficult to diagnose skin cancers […]

In this seminar two MVA members, TECHNIA and Novo Nordisk, join forces to share more holistic insights about digital trends and tools for sustainable and compliant product creation and warmly welcome you. The Life Sciences industry can create products faster and more efficiently, while ensuring long-term business sustainability and compliancy by understanding trends and taking […]

The transition from early (phase 1, expansion cohorts and single-arm phase 2) trials to later phases of clinical development poses several challenges. While many of these challenges are of strategic and financial natures, some usual methodological pitfalls can be addressed in a somewhat systematic fashion. In this presentation, we will explore these pitfalls and attempt […]

Recent years have seen a resurgence and rapid growth in the field of cell and gene therapies as therapeutic options to treat diverse clinical indications including neuromuscular diseases, ophthalmic disorders, haemophilia, cancers and much more. Designing and executing a complete bioanalytical strategy to support the preclinical and clinical development of cell and gene therapies can […]

Join MVA and Catalent at this Boost Seminar focusing on optimizing oral bioavailability and translating formulation advances for clinical success. Oral solid dosage forms remain a preferred option for many pharmaceutical drug developers. However, their successful development and manufacture still present several unique challenges and opportunities. This event brings together pharmaceutical experts to discuss such […]

Medicon Valley Alliance R&D Network is proud to present winner of the Nobel Prize in Chemistry 2022, Professor Morten Meldal. Professor Meldal will give a lecture on his groundbreaking work on what’s known as ‘click chemistry’, a chemical reaction that has made it possible to ‘glue’ molecules together. The method is a very useful tool, […]

MVA facilitates a debate at Folkemødet 2023 where a strong panel will discuss how innovation projects such as ReproUnion, DiaUnion and HALRIC can continue to attract, grow and plant the seeds for new businesses!

Join us for this event to explore the lessons learned by senior industry experts who have successfully developed, launched, and commercialised global assets. Through a combination of real-life case-studies, panel discussions, and presentations we will explore how and when you should build your market access and commercialisation strategies, no matter your corporate strategy. This seminar […]

In recent years, pharmaceutical outsourcing of bioanalysis has grown tremendously. Simultaneously, bioanalytical programs have become more complex due to increasing regulatory demands. While a comprehensive understanding of the regulatory guidelines is required to develop a winning bioanalytical strategy, several other challenges, such as strategic timing, are common with outsourcing. Additionally, the regulatory environment of bioanalysis […]

Medicon Valley Alliance and Worldwide Clinical Trials are pleased to invite you to a Good Morning Meeting on the 24th of May in Copenhagen focusing on Rare but achievable – factors for successfully navigating rare oncology trials. Conducting clinical trials in rare oncology populations can have its challenges. This event – designed for C-level Executives, […]

Members of Medicon Valley Alliance are invited to attend the Extraordinary General Assembly 2023. The proposal to amend the articles of association was unanimously adopted by the members present at the ordinary general meeting on 19 April 2023, but §17 of the articles of association requires that at least 2/3 of all votes are also […]